Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Novel factor VIIa inhibitors identified at Aventis

May 27, 2002

Thrombin inhibitors in development at 3-Dimensional

May 24, 2002

Trypsin-like serine protease inhibitors patented by BioCryst

May 22, 2002

Novel gpIbIX antagonists in the Merck pipeline

May 21, 2002

New factor Xa inhibitors patented by Sankyo

May 17, 2002

Oral heparin fails to prove superiority to Lovenox in prevention of DVT

May 16, 2002

Buccal heparin completes proof-of-concept study

May 16, 2002

U.K. launch for synthetic pentasaccharide for reducing the risk of venous thromboembolism

May 15, 2002

Merck presents new series of thrombin inhibitors

May 14, 2002

Benzamidine derivatives from Genentech inhibit serine proteases involved in thrombosis

May 14, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.